estriol has been researched along with leuprolide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Ando, K; Kikuchi, A; Matsumi, H; Momoeda, M; Nakayama, H; Osuga, Y; Sagara, Y; Taketani, Y; Wang, Y; Watanabe, M; Yano, T | 1 |
| Ando, K; Kasai, Y; Kikuchi, A; Matsumi, H; Okagaki, R; Osuga, Y; Taketani, Y; Wang, Y; Watanabe, M; Yano, N; Yano, T | 1 |
| Candeloro, G; Desideri, G; Necozione, S; Piazze, J; Rea, S; Recchia, CO; Recchia, F | 1 |
1 trial(s) available for estriol and leuprolide
| Article | Year |
|---|---|
Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata.
Topics: Absorptiometry, Photon; Adult; Antineoplastic Agents, Hormonal; Bone Density; Delayed-Action Preparations; Estriol; Female; Humans; Leiomyoma; Leuprolide; Lumbar Vertebrae; Middle Aged; Osteoporosis; Uterine Neoplasms | 1999 |
3 other study(ies) available for estriol and leuprolide
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the effects of add-back therapy with various natural oestrogens on bone metabolism in rats administered a long-acting gonadotrophin-releasing hormone agonist.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Estriol; Estrogens; Estrone; Female; Femur; Gonadotropin-Releasing Hormone; Leuprolide; Osteocalcin; Rats; Rats, Sprague-Dawley; Spine | 2000 |
Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy.
Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Estriol; Estrogen Antagonists; Female; Humans; Ifosfamide; Leuprolide; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Triazoles; Tumor Necrosis Factor Ligand Superfamily Member 15 | 2011 |